FrieslandCampina Ingredients has secured regulatory approval for its innovative milk fat globule membrane (MFGM) ingredient, Vivinal MFGM, in Thailand. This approval allows the ingredient to be incorporated into infant formulas and various food products. Vivinal MFGM is derived from unpasteurized cheese whey through a gentle processing method, containing essential proteins, lipids, and bioactive components like phospholipids, immunoglobulin G, and lactoferrin. Clinical research indicates that MFGM supports cognitive development in infants and reduces the risk of middle ear infections. Additionally, recent studies have demonstrated its anti-viral properties against respiratory syncytial virus. Manufacturers can now leverage this ingredient for a broad range of infant and young child nutrition products in Thailand, where the infant formula market is valued at $865 million and projected to grow steadily.

The approval of Vivinal MFGM marks a significant advancement in infant nutrition within Thailand. The ingredient's unique composition offers substantial health benefits, making it an ideal addition to premium infant formulas. The inclusion of bioactive proteins and other beneficial components aligns with the growing trend of premiumization in the infant formula market. In Thailand, 74% of new infant formula launches in 2024 featured at least one bioactive ingredient, reflecting consumer demand for high-quality products. This shift underscores the importance of ingredients like Vivinal MFGM, which not only meet rigorous safety standards but also provide added value to infant nutrition.

Sophie Nicolas, the marketing lead for APAC – Early Life Nutrition at FrieslandCampina Ingredients, highlighted the significance of this achievement. She emphasized the company's dedication to delivering top-tier ingredients that enhance infant formulas, especially in scenarios where breastfeeding is not feasible. The approval paves the way for brands to innovate and offer superior nutritional options for infants, ensuring they receive the necessary nutrients for optimal growth and development. The potential impact on the Thai market is considerable, given its robust growth trajectory and increasing focus on premium infant nutrition solutions.

The regulatory green light for Vivinal MFGM represents a pivotal moment for both FrieslandCampina Ingredients and the broader infant formula industry in Thailand. It opens up new opportunities for manufacturers to develop advanced products that cater to the evolving needs of consumers. By integrating this cutting-edge ingredient, brands can provide families with high-quality infant formulas that support healthy development. This milestone underscores the commitment to innovation and safety, ensuring that more infants in Thailand can benefit from enhanced nutritional offerings tailored to their specific requirements.